Literature DB >> 24000247

Thoracic Oncology HERMES syllabus: setting the basis for thoracic oncology training in Europe.

Fernando Gamarra, Paolo Boffetta, Dirk De Ruysscher, Enriqueta Felip, Mina Gaga, Bogdan Grigoriu, Rudolf M Huber, Sam M Janes, Charles Hugo Marquette, Gilbert Massard, Julie-Lyn Carrillo Noel, Jean-Paul Sculier, Anne-Pascale Meert.   

Abstract

Mesh：

Year:  2013        PMID： 24000247     DOI： 10.1183/09031936.00094613

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

1.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

Review 2.  Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.

Authors:  Fernando Gamarra; Julie-Lyn Noël; Alessandro Brunelli; Anne-Marie C Dingemans; Enriqueta Felip; Mina Gaga; Bogdan Dragos Grigoriu; Georgia Hardavella; Rudolf M Huber; Samuel Janes; Gilbert Massard; Paul Martin Putora; Jean-Paul Sculier; Philipp A Schnabel; Sara Ramella; Dirk Van Raemdonck; Anne-Pascale Meert
Journal:  Breathe (Sheff)       Date:  2016-09

3.  Continuous professional development: elevating thoracic oncology education in Europe.

Authors:  Wouter H van Geffen; Torsten G Blum; Stefano Aliberti; Kevin G Blyth; Clementine Bostantzoglou; Amy Farr; Bogdan Grigoriu; Georgia Hardavella; Rudolf M Huber; Nick Maskell; Gilbert Massard; Najib M Rahman; Daiana Stolz; Jan van Meerbeeck
Journal:  Breathe (Sheff)       Date:  2019-12

Review 4.  Why do we need harmonization in thoracic surgery: a view from above by the European Union of Medical Specialists.

Authors:  Toni Lerut; Dirk Van Raemdonck; Gilbert Massard
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.